Medical treatment of actinic keratoses and superficial skin cancers: diclofenac
نویسندگان
چکیده
منابع مشابه
Medical treatment of actinic keratoses and superficial skin cancers: diclofenac
In patients who develop early signs of fotocarcinogenesi, the actinic keratosis are one of the most frequent events that can lead to problems of therapeutic management, especially if for business reasons or lifestyle, they are repeatedly and chronically exposed to the sun. In these patients the lesions are often widespread and recurrent, and may require repeated treatment cycles. It is in these...
متن کاملMethyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Methyl aminolevulinate-hydrochloride cream (Metvix [in Canada] and Metvixia [in the US], Galderma) in combination with photodynamic therapy (PDT) provides an effective treatment option for actinic keratoses (AKs), superficial basal cell carcinoma (sBCC), and Bowen's disease (BD). Good clinical outcomes have been reported in the literature. Complete responses (CRs) in AK range from 69% to 93% at...
متن کاملDiclofenac gel in the treatment of actinic keratoses
Actinic keratoses are areas of intraepithelial neoplasia for which treatment is necessary. Because they arise in areas of sun damage, it is desirable to treat the entire damaged field to not only treat visible lesions, but also subclinical, emerging malignancies, ie, "field therapy", 5-fluorouracil, imiquimod, and diclofenac are all treatment options, and are discussed and compared.
متن کاملTreatment of actinic keratoses
illions of vacationers deliberately expose themselves to excessive UV radiation. As a result, the risk of UVrelated skin damage is rapidly increasing. Sun worshippers thus have to expect an increased risk for actinic keratoses (a carcinoma in situ). Most recent estimates prove that about 8 million Germans suffer from actinic keratoses. There is an estimated prevalence of about 15 percent among ...
متن کاملCutaneus cancers in elderly Medical treatment of actinic keratosis and superficial coutaneus cancers: imiquimod
Conclusions The treatment of certain non-melanoma coutaneous toumors with imiquimod 5% cream, has been effective, without collateral effects; erythema, edema, vesicles, crusts and erosions with itching or burning in the application area, have been the most frequent adverse events which however did not cause the suspension of therapy. A diligent and continuative follow-up is necessary. Published...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Geriatrics
سال: 2010
ISSN: 1471-2318
DOI: 10.1186/1471-2318-10-s1-l48